{"title":"有晶状体人工晶体矫正近视并发症的研究","authors":"Mosavi Sa","doi":"10.23880/oajo-16000214","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate the visual outcomes and complications of phakic intraocular lenses Implantation for myopia. Method: This cross sectional study included 151 myopic eyes implanted with one of the three types of phakic intraocular lenses (Artisan 83 eyes, ICL 52 eyes, and I- Care 16 eyes). Patients were followed for an average of 33±15 months. Intraoperative and postoperative complications were recorded as short- term and long-term. All patients were recalled and examined under thorough eye examination. Results: Three years after the surgery, safety index has changed significantly using the Artisan and ICL lenses respectively (P>0.001 and P 0.007=) and efficacy index in the three groups was 0.04 ± 0.91, 0.14± 1.61 and ± 0.42 0.15. Spherical Equivalent (SE) values decreased post operation that was statistically significant (P 001/0>) using Artisan and ICL lenses. Also, Astigmatism values dropped significantly using Artisan and I-care lenses (P 001/0> and P 03/0=) three years after surgery. Endothelial cell count reduction percentage was 6.1% and 5.2% in groups Arti san and ICL respectively, while it was 43.7% in Group ICare. Conclusion: No significant intraoperative complication was seen among the three groups. However, sharp decline of post operatively corneal endothelial cell count was the most important complication of I- Care lens and it is suggested to prevent implantation of this type of PIOLs for anticipation of cornea decompensation.","PeriodicalId":91939,"journal":{"name":"Open access journal of ophthalmology","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Study of Complications of Phakic Intraocular Lenses in Correction of Myopia\",\"authors\":\"Mosavi Sa\",\"doi\":\"10.23880/oajo-16000214\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To evaluate the visual outcomes and complications of phakic intraocular lenses Implantation for myopia. Method: This cross sectional study included 151 myopic eyes implanted with one of the three types of phakic intraocular lenses (Artisan 83 eyes, ICL 52 eyes, and I- Care 16 eyes). Patients were followed for an average of 33±15 months. Intraoperative and postoperative complications were recorded as short- term and long-term. All patients were recalled and examined under thorough eye examination. Results: Three years after the surgery, safety index has changed significantly using the Artisan and ICL lenses respectively (P>0.001 and P 0.007=) and efficacy index in the three groups was 0.04 ± 0.91, 0.14± 1.61 and ± 0.42 0.15. Spherical Equivalent (SE) values decreased post operation that was statistically significant (P 001/0>) using Artisan and ICL lenses. Also, Astigmatism values dropped significantly using Artisan and I-care lenses (P 001/0> and P 03/0=) three years after surgery. Endothelial cell count reduction percentage was 6.1% and 5.2% in groups Arti san and ICL respectively, while it was 43.7% in Group ICare. Conclusion: No significant intraoperative complication was seen among the three groups. However, sharp decline of post operatively corneal endothelial cell count was the most important complication of I- Care lens and it is suggested to prevent implantation of this type of PIOLs for anticipation of cornea decompensation.\",\"PeriodicalId\":91939,\"journal\":{\"name\":\"Open access journal of ophthalmology\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open access journal of ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23880/oajo-16000214\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open access journal of ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/oajo-16000214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Study of Complications of Phakic Intraocular Lenses in Correction of Myopia
Objective: To evaluate the visual outcomes and complications of phakic intraocular lenses Implantation for myopia. Method: This cross sectional study included 151 myopic eyes implanted with one of the three types of phakic intraocular lenses (Artisan 83 eyes, ICL 52 eyes, and I- Care 16 eyes). Patients were followed for an average of 33±15 months. Intraoperative and postoperative complications were recorded as short- term and long-term. All patients were recalled and examined under thorough eye examination. Results: Three years after the surgery, safety index has changed significantly using the Artisan and ICL lenses respectively (P>0.001 and P 0.007=) and efficacy index in the three groups was 0.04 ± 0.91, 0.14± 1.61 and ± 0.42 0.15. Spherical Equivalent (SE) values decreased post operation that was statistically significant (P 001/0>) using Artisan and ICL lenses. Also, Astigmatism values dropped significantly using Artisan and I-care lenses (P 001/0> and P 03/0=) three years after surgery. Endothelial cell count reduction percentage was 6.1% and 5.2% in groups Arti san and ICL respectively, while it was 43.7% in Group ICare. Conclusion: No significant intraoperative complication was seen among the three groups. However, sharp decline of post operatively corneal endothelial cell count was the most important complication of I- Care lens and it is suggested to prevent implantation of this type of PIOLs for anticipation of cornea decompensation.